Tahira Younis

Dr. Tahira Younis

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Saudi Journal of Biological Sciences
Verified
Journal Article
Open access
TRTehreem Raza
Tehreem Raza
Bilal RASOOLBilal RASOOL
Bilal RASOOL
AAAsrar Asrar Asrar
Asrar Asrar Asrar
MMMaleeha Manzoor
Maleeha Manzoor
Zeeshan JavedZeeshan Javed
Zeeshan Javed
TYTahira Younis
Tahira Younis
Due to the increased production of polyacrylamide microplastics in the environment impacting the adverse effects on aquatic organisms have become a global concern. The present study aimed to evaluate the toxicity of different concentrations (0.018, 0.03 0.09 g/1) of polyacrylamide microplastics on Oreochromis niloticus. Polyacrylamide microplastics were characterized by Fourier transform infrared and Raman spectroscopy. The FTIR technique revealed the spherical morphology and size range of polyacrylamide (0.1–0.4 mm) with 99 % purity. Raman Spectroscopy results showed peaks around (1100 cm−1 and 1650 cm−1) in gills, these peaks confirmed the presence of polyacrylamide microplastics in the gills of Oreochromis niloticus. Polyacrylamide microplastics significantly shortened the antioxidant enzymes (Catalase and Reduced glutathione) proceedings and the increase was observed in Malondialdehyde and Lipid peroxide levels in high-dose treated groups. Moreover, total protein contents were expressively increased, while other blood parameters (AST, ALP, ALT) were significantly decreased. Hemoglobin (g/dl), Erythrocyte (106/µl) and TLC (1x109/l) levels were reduced significantly (p < 0.05) in high concentrations. The administration of polyacrylamide microplastics induced different histological changes in the gills, liver and intestine of O. niloticus. It was concluded that polyacrylamide microplastics are toxic agents having harmful effects on fish health.

2 May 2023 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
SSSamina Shabbir
Samina Shabbir
WWWeiting Wang
Weiting Wang
MNMohsin Nawaz
Mohsin Nawaz
PBPrerona Boruah
Prerona Boruah
Md. F. KulyarMd. F. Kulyar
Md. F. Kulyar
MHMingxiong He
Mingxiong He
Acetic acid and furfural (AF) are two major inhibitors of microorganisms during lignocellulosic ethanol production. In our previous study, we successfully engineered Zymomonas mobilis 532 (ZM532) strain by genome shuffling, but the molecular mechanisms of tolerance to inhibitors were still unknown. Therefore, this study investigated the responses of ZM532 and its wild-type Z. mobilis (ZM4) to AF using multi-omics approaches (transcriptomics, genomics, and label free quantitative proteomics). Based on RNA-Seq data, two differentially expressed genes, ZMO_RS02740 (up-regulated) and ZMO_RS06525 (down-regulated) were knocked out and over-expressed through CRISPR-Cas technology to investigate their roles in AF tolerance. Overall, we identified 1865 and 14 novel DEGs in ZM532 and wild-type ZM4. In contrast, 1532 proteins were identified in ZM532 and wild-type ZM4. Among these, we found 96 important genes in ZM532 involving acid resistance mechanisms and survival rates against stressors. Furthermore, our knockout results demonstrated that growth activity and glucose consumption of mutant strains ZM532∆ZMO_RS02740 and ZM4∆ZMO_RS02740 decreased with increased fermentation time from 42 to 55 h and ethanol production up to 58% in ZM532 than that in ZM532∆ZMO_RS02740. Hence, these findings suggest ZMO_RS02740 as a protective strategy for ZM ethanol production under stressful conditions.

18 September 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AIAli Raza Ishaq
Ali Raza Ishaq
ABAneela Bashir
Aneela Bashir
IFIqra Farzeen
Iqra Farzeen
HEHeba A. S. El-Nashar
Heba A. S. El-Nashar
FDFarah Deeba
Farah Deeba
TYTahira Younis
Tahira Younis
Wound healing remains a significant clinical challenge, driving the need for innovative natural therapeutics. This study investigated F. xanthoxyloides bark methanolic extract (FXBM) using integrated in vitro, in vivo, and in silico approaches. LC-ESI-MS/MS identified eight bioactive compounds: gallic acid, cinnamaldehyde, coumaric acid, sinapic acid, vanillic acid, caffeic acid, hydroxybenzoic acid, and quercetin. FXBM demonstrated high cell viability (122.35 ± 2.72% and 126.02 ± 0.9%) at 20 µg/mL in HaCaT keratinocytes and NIH3T3 fibroblasts, respectively. Scratch assays showed dose-dependent wound closure, with 20 µg/mL FXBM achieving near-complete closure in both cell lines after 48 h. It also protected HaCaT cells from apoptosis, reducing total apoptotic cells by 75% at 20 µg/mL. In BALB/c mice, 10% FXBM gel achieved 99.79 ± 0.083% wound closure by day 21, comparable to 1% silver sulfadiazine. Histology confirmed enhanced collagen deposition, re-epithelialization, and hair follicle regeneration. FXBM activated antioxidant defenses by reducing malondialdehyde and enhancing superoxide dismutase and catalase activities. It dually regulated inflammation by decreasing TNF-α, IL-6, and IL-1β while upregulating VEGF, and activated the Nrf2/HO-1 pathway and MMP-1-mediated tissue remodeling. In silico analysis confirmed Lipinski compliance; network pharmacology identified EGFR, STAT3, MMP9, TLR4, and RELA as key targets, with GO/KEGG implicating oxidative stress, NF-κB, and MAPK signaling. Molecular docking showed strong binding affinities, with sinapic acid exhibiting highest affinity for MMP-1 (− 6.8 kcal/mol). These findings establish F. xanthoxyloides as a promising wound-healing candidate for clinical translation.

4 June 2026 in PLOS ONE
Verified
Journal Article
Open access
MSMashal Shahzadi
Mashal Shahzadi
TYTahira Younis
Tahira Younis
AAAyman M. Al-Qaaneh
Ayman M. Al-Qaaneh
AIAli Raza Ishaq
Ali Raza Ishaq
FDFarah Deeba
Farah Deeba
HEHeba Elnashar
Heba Elnashar
Fraxinus xanthoxyloides Wall. ex DC (Family-Oleaceae) is a tiny tree found in arid highlands, often referred to as “Afghan ash”. This study aimed to explore F. xanthoxyloides bark extract as a potential anti-diabetic agent by conducting GC-MS analysis along with in vitro and in vivo studies. F. xanthoxyloides bark methanol extract (FXBM) was fractionated with n-hexane (FXBH), followed by chloroform (FXBC), ethyl acetate (FXBE), and residual aqueous fraction (FXBA). GC-MS and HPLC-MS analysis of the total extract were performed. The inhibitory activities against α-amylase, α-glucosidase, and DPP4 were assessed for the extract and its fractions. The in vivo study included five groups: control group, diabetic control, groups pretreated with alloxan (150 mg/kg) + glibenclamide (5 mg/kg), group pretreated with alloxan (150 mg/kg) + FXBH (200 mg/kg), and group pretreated with alloxan (150 mg/kg) + FXBH (400 mg/kg). Further, a histopathological investigation was conducted. GC-MS analysis of FXBM revealed the presence of 17 compounds predominated by esters (17.9%), polyols (16.35%), and O -glycosides (12.24%). Among all extract/fractions, FXBH showed maximum α-amylase, α-glucosidase, and DPP4 inhibition when compared to acarbose and berberine, respectively. It also achieved the highest glucose uptake among all extract/fractions when compared with metformin. HPLC-DAD analysis showed the presence of gallic acid (3.29 µg/mg), catechin (4.23 µg/mg), caffeic acid (6.05 µg/mg), ferulic acid (2.99 µg/mg), and quercetin (6.4 µg/mg). FXBH-treated rats showed a significant increase in body weight and reduced blood glucose levels ( p < 0.05) from days 1–30. The biochemical parameters like triglyceride, low-density lipoprotein, cholesterol, lipase, amylase, C-reactive protein, alanine aminotransferase, aspartate aminotransferase, creatinine, HbA1c, and urea were decreased, while high-density lipoprotein was elevated, compared to diabetic control. Histopathological studies demonstrated restoration of pancreatic β-cells. In conclusion, F. xanthoxyloides bark extract exhibited potential antidiabetic effects; meanwhile, further studies are recommended to characterize the pharmacodynamics, pharmacokinetics, and synergistic effects with standard drugs.